Pharmafile Logo

Freyr Solutions

Freyr is a Global Regulatory Solutions and Services company, focusing on the entire Regulatory value-chain ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions to post approval maintenance, Labeling, Artwork Change Management for Pharmaceutical, Generics, Medical Device, biotechnology, Biosimilar, Consumer Healthcare, Cosmetic companies across the globe.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

150 College Road West, Ste 102, Princeton, NJ, USA
9084837958

 Latest Content from PMHub 

The brand strategy revolution

Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need.

How Medisafe is using AI to improve patient adherence

Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence.

Downloadable Pack: Understanding Multiple Sclerosis

Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry.

Six factors that drive a multiple sclerosis patient’s choice of disease-modifying therapy

MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget.

Innovative approaches in the treatment of multiple sclerosis

Blue Latitude Health Senior Associate Consultant Will Frostick delves into the MS treatment landscape and explores some of the cutting-edge treatments on the horizon.

Mobilising the public to combat the antimicrobial resistance crisis

Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. So why doesn’t the public seem bothered? BLH Account Executive Ford Stewart examines...

Leading Edge, a Lucid Group company, strengthens its senior client services team

Leading Edge, a Lucid Group company, is delighted to announce the appointment of its new Lead Client Partnership Director, Frances O’Connor.Frances is an experienced strategic healthcare communicator with expertise in...

From Cowgirl to Medical Writer – How did that happen?

Amy Jackson, Editorial Director, Lucid Group discusses her unlikely path into Medical Communications.

Measures for measures

Why pharma’s marketing metrics must close the loop

My adventure into the world of Medcomms and Lucid’s Futures Academy

After finishing my PhD, I was disillusioned with the lab. I felt that I wanted more out of my career than working on one protein, in one pathway, for the...